Your browser doesn't support javascript.
loading
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Loriot, Yohann; Texier, Matthieu; Culine, Stéphane; Fléchon, Aude; Thiery-Vuillemin, Antoine; Gravis, Gwenaëlle; Geoffrois, Lionel; Chevreau, Christine; Gross-Goupil, Marine; Barthelemy, Philippe; Bompas, Emmanuelle; Mahammedi, Hakim; Laguerre, Brigitte; Lacourtoisie, Sophie Abadie; Helissey, Carole; Ladoire, Sylvain; Abraham, Christine; Massard, Christophe; Grimaldi, Serena; Fizazi, Karim.
Afiliação
  • Loriot Y; Gustave Roussy, Département de médecine oncologique, INSERM U981, Université Paris-Saclay, Villejuif, France. Electronic address: yohann.loriot@gustaveroussy.fr.
  • Texier M; Gustave Roussy, INSERM U1018, Université Paris Saclay, Villejuif, France.
  • Culine S; Department of Medical Oncology, Saint-Louis-APHP, Faculté de Paris, Paris, France.
  • Fléchon A; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.
  • Thiery-Vuillemin A; Service d'Oncologie médicale, CHU Besançon, Besançon, France.
  • Gravis G; Department of Medical Oncology, Paoli-Calmette Institute, Marseille, France.
  • Geoffrois L; Medical Oncology, Institute of Cancerology of Lorraine - Alexis Vautrin, Vandoeuvre Les Nancy, France.
  • Chevreau C; Department of Medical Oncology, Institut Claudius Regaud IUCT-O, Toulouse, France.
  • Gross-Goupil M; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.
  • Barthelemy P; Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.
  • Bompas E; Medical Oncology Department, ICO, Saint Herblain, Pays de la Loire, France.
  • Mahammedi H; Centre Jean Perrin, Clermont-Ferrand, France.
  • Laguerre B; Department of Medical Oncology, Eugene Marquis Cancer Center, Rennes, France.
  • Lacourtoisie SA; Western Cancer Institute, Paul Papin Site, Angers, France.
  • Helissey C; Clinical Research Unit, Military Hospital Begin, Saint Mandé, France.
  • Ladoire S; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Abraham C; Department of Medical Oncology, Centre Hospitalier Versailles André Mignot, Le Chesnay, France.
  • Massard C; Gustave Roussy, DITEP, Université Paris-Saclay, Villejuif, France.
  • Grimaldi S; Gustave Roussy, Department of Nuclear Medicine and Endocrine Oncology, Université Paris-Saclay, Villejuif, France.
  • Fizazi K; Gustave Roussy, Département de médecine oncologique, INSERM U981, Université Paris-Saclay, Villejuif, France.
Eur Urol ; 82(2): 172-179, 2022 08.
Article em En | MEDLINE | ID: mdl-35599187
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Seminoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Seminoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article